Viewing Study NCT02075034


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-03-05 @ 5:08 AM
Study NCT ID: NCT02075034
Status: WITHDRAWN
Last Update Posted: 2020-07-01
First Post: 2014-02-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Three Dosing Schedules of Oral Rigosertib in MDS Patients
Sponsor: Traws Pharma, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: Onconova 09-10
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators